GlassScriptPhysician profile
Jeremy James Flood
NPI 1639203128
$2,770.25
in general payments reported to CMS, 2019-2025
5 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $323 · 2020: $197 · 2021: $350 · 2024: $1,787 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,560 · Food and Beverage: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,560.00 |
| Food and Beverage | $339.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,610.00 | 2024 | Tepezza |
| Sanofi-Aventis U.S. LLC | $451.75 | 2020-2021 | |
| Novo Nordisk INC | $391.41 | 2019-2025 | |
| Abbott Laboratories | $192.09 | 2019-2024 | Freestyle Libre 3 |
| Valeritas, INC. | $125.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremy Flood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.